pharma stock

Latest Headlines

Latest Headlines

Fidelity mutual fund rides big pharma profits

Boasting a 12-month return of 27.3%--more than 10% better than both the Dow Jones Industrial Average and the S&P 500 returns--the Fidelity Select Pharmaceutical Portfolio recognizes "a lot of

AZ, BMS, Lilly, Pfizer make investor's cut

Investor Osman Gulseven finds that of hundreds of healthcare companies listed on the New York Stock Exchange, only four fit his investment objective of high profitability, substantial dividends and

Constantino defies Cramer on pharma stocks: Buy

Mad Money host Jim Cramer has not gotten the last word on his recent advice to investors to sell their big pharma stocks. Seeking Alpha contributor Frank Constantino says if investors shift to

Cramer on big pharma: Sell

Mad money man Jim Cramer last week articulated his view of the giants in the pharma industry. "This is just one expensive graveyard of stocks," he said on his CNBC program. Cramer cites the usual